Neoadjuvant Gastric Score: How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit.

Chase J WehrleCaleb N SeaveyJenny ChangKatherine StackhouseKimberly WooToms AugustinDaniel JoyceRobert SimonR Matthew WalshSamer A Naffouje

Published in: Annals of surgical oncology (2023)

NAR score may be repurposed to generate a prognostic tool in gastric adenocarcinoma to predict 5-year OS and has the potential to guide decision-making regarding allocation of adjuvant therapy. Further studies should prospectively validate these findings to confirm clinical utility.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
decision making
squamous cell carcinoma
lymph node
radiation therapy
sentinel lymph node
early stage
climate change